Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01894061
Title NovoTTF-100A With Bevacizumab (Avastin) in Patients With Recurrent Glioblastoma
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Case Comprehensive Cancer Center
Indications

glioblastoma

gliosarcoma

Therapies

Bevacizumab

Age Groups: adult
Covered Countries USA


No variant requirements are available.